A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant

Locations

Canada

Start date

17/07/2026

Identifiers

Trial ID NN9559-8619,
NCT number NCT07710729,
Eudract number Not Available

Summary

The purpose of this clinical study is to find out if UBT251 is safe and effective to be taken together with medicines, like birth control tablets, and emptying of the stomach in women not able to become pregnant living with overweight or obesity

Trial Overview:

Condition

Overweight

Obesity

Treatment

DRUG: UBT251

DRUG: Oral contraceptive

DRUG: Acetaminophen

Study type

INTERVENTIONAL

Trial duration

Jul 17 2026 - Apr 27 2027

Participants

Phase

Are you eligible?

Gender

FEMALE

Age

18 to 65 years old

Find out how you can participate

Questions or concerns

Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.